Home
CRSP
CRSP News

Latest CRISPR Therapeutics AG (CRSP) News on April 19, 2025

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks

2 days ago

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

MT Newswires

2 days ago

BofA Adjusts Price Target on CRISPR Therapeutics to $80 From $86, Keeps Buy Rating

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 25% Price Increase Over Last Week

Simply Wall St.

3 days ago

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 25% Price Increase Over Last Week

3 Magnificent Stocks That Could Double or More by 2030

Motley Fool

7 days ago

3 Magnificent Stocks That Could Double or More by 2030

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

Motley Fool

8 days ago

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?

CRISPR Therapeutics AG (CRSP) Stock Moves -1.81%: What You Should Know

Zacks

9 days ago

CRISPR Therapeutics AG (CRSP) Stock Moves -1.81%: What You Should Know

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Zacks

10 days ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street

Motley Fool

12 days ago

4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Motley Fool

12 days ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 12% Weekly Dip Following COO Resignation

Simply Wall St.

14 days ago

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 12% Weekly Dip Following COO Resignation

CRISPR Therapeutics AG (CRSP) Stock Moves -0.03%: What You Should Know

Zacks

15 days ago

CRISPR Therapeutics AG (CRSP) Stock Moves -0.03%: What You Should Know

Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March

Motley Fool

16 days ago

Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire

16 days ago

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

MT Newswires

16 days ago

RBC Cuts Price Target on CRISPR Therapeutics to $38 From $48, Keeps Sector Perform, Speculative Risk

Biotech stocks slide as Marks resignation seen being negative for sector

TipRanks

18 days ago

Biotech stocks slide as Marks resignation seen being negative for sector

Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.'s 'Misinformation And Lies'

Investor's Business Daily

19 days ago

Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.'s 'Misinformation And Lies'

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today

Motley Fool

19 days ago

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today

Intellia Focuses on Pipeline Development Amid Stiff Competition

Zacks

19 days ago

Intellia Focuses on Pipeline Development Amid Stiff Competition

Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns

Investor's Business Daily

19 days ago

Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns

The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics

Zacks

19 days ago

The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics

Promising Genomics & Synthetic Biology Stocks to Consider in 2025

Zacks

22 days ago

Promising Genomics & Synthetic Biology Stocks to Consider in 2025

Novo gains Lexicon obesity drug; CRISPR COO to step down

BioPharma Dive

22 days ago

Novo gains Lexicon obesity drug; CRISPR COO to step down

CRISPR Therapeutics (NasdaqGM:CRSP) COO Departure Announced Following 7% Share Price Decline

Simply Wall St.

23 days ago

CRISPR Therapeutics (NasdaqGM:CRSP) COO Departure Announced Following 7% Share Price Decline

MT Newswires

24 days ago

CRISPR Therapeutics COO to Step Down

CRISPR Therapeutics Announces Transition of Chief Operating Officer

GlobeNewswire

24 days ago

CRISPR Therapeutics Announces Transition of Chief Operating Officer

This CRISPR Therapeutics Insider Increased Their Holding In The Last Year

Simply Wall St.

24 days ago

This CRISPR Therapeutics Insider Increased Their Holding In The Last Year

Is CRISPR Therapeutics AG (CRSP) a Promising Biotech Stock According to Wall Street Analysts

Insider Monkey

25 days ago

Is CRISPR Therapeutics AG (CRSP) a Promising Biotech Stock According to Wall Street Analysts

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

25 days ago

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

2 Beaten-Down Stocks to Buy on the Dip

Motley Fool

a month ago

2 Beaten-Down Stocks to Buy on the Dip

CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing

As The Biotech Sector Remains Strong, Vertex Stock Trades Near Buy Point

Investor's Business Daily

a month ago

As The Biotech Sector Remains Strong, Vertex Stock Trades Near Buy Point

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors

2 No-Brainer Biotech Stocks to Buy Right Now

Motley Fool

a month ago

2 No-Brainer Biotech Stocks to Buy Right Now

Is CRISPR Therapeutics (CRSP) One of the Most Shorted Stocks in 2025?

Insider Monkey

a month ago

Is CRISPR Therapeutics (CRSP) One of the Most Shorted Stocks in 2025?

CRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?

Zacks

a month ago

CRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?

CRISPR Therapeutics AG (CRSP): A Bull Case Theory

Insider Monkey

a month ago

CRISPR Therapeutics AG (CRSP): A Bull Case Theory

CRISPR Therapeutics (CRSP): Among Top Stocks to Buy from Ark Invest’s Portfolio

Insider Monkey

a month ago

CRISPR Therapeutics (CRSP): Among Top Stocks to Buy from Ark Invest’s Portfolio

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Zacks

a month ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Why Is CRISPR Therapeutics (CRSP) Up 0.4% Since Last Earnings Report?

Zacks

a month ago

Why Is CRISPR Therapeutics (CRSP) Up 0.4% Since Last Earnings Report?

ElevateBio taps Amazon’s genAI tools to design CRISPR therapeutics

Pharmaceutical Technology

a month ago

ElevateBio taps Amazon’s genAI tools to design CRISPR therapeutics

Shareholders in CRISPR Therapeutics (NASDAQ:CRSP) are in the red if they invested a year ago

Simply Wall St.

a month ago

Shareholders in CRISPR Therapeutics (NASDAQ:CRSP) are in the red if they invested a year ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 03/03/2025

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.

Motley Fool

2 months ago

3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.

CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

GlobeNewswire

2 months ago

CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall Street

Motley Fool

2 months ago

2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall Street

CRISPR Therapeutics AG (CRSP): the Most Oversold Pharma Stock to Buy According to Analysts

Insider Monkey

2 months ago

CRISPR Therapeutics AG (CRSP): the Most Oversold Pharma Stock to Buy According to Analysts

CRISPR Therapeutics AG (CRSP): Among the Most Oversold Healthcare Stocks to Buy Now

Insider Monkey

2 months ago

CRISPR Therapeutics AG (CRSP): Among the Most Oversold Healthcare Stocks to Buy Now

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It

CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?

Zacks

2 months ago

CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?

Investing.com

2 months ago

Street Calls of the Week

Why CRISPR Therapeutics (CRSP) Soared on Friday?

Insider Monkey

2 months ago

Why CRISPR Therapeutics (CRSP) Soared on Friday?

CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99

GuruFocus.com

2 months ago

CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99

CRISPR Therapeutics Stock Upgrade Following Analyst Reassessment

GuruFocus.com

2 months ago

CRISPR Therapeutics Stock Upgrade Following Analyst Reassessment

Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday

Motley Fool

2 months ago

Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday

Morningstar Research

2 months ago

Analyst Report: CRISPR Therapeutics AG

Crispr Therapeutics price target raised to $86 from $85 at BofA

TipRanks

2 months ago

Crispr Therapeutics price target raised to $86 from $85 at BofA

CRISPR Therapeutics Q4 Earnings and Revenues Surpass Estimates

Zacks

2 months ago

CRISPR Therapeutics Q4 Earnings and Revenues Surpass Estimates

MT Newswires

2 months ago

Truist Securities Adjusts Price Target on CRISPR Therapeutics to $120 From $100, Keeps Buy Rating

MT Newswires

2 months ago

TD Cowen Upgrades CRISPR Therapeutics to Hold From Sell, Adjusts Price Target to $35 From $30

MT Newswires

2 months ago

RBC Lowers Price Target on CRISPR Therapeutics to $48 From $53, Keeps Sector Perform, Speculative Risk

MT Newswires

2 months ago

CRISPR Therapeutics Swings to Q4 Loss, Revenue Falls

CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Tops Revenue Estimates

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Tops Revenue Estimates

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

2 months ago

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

MT Newswires

2 months ago

BofA Securities Adjusts CRISPR Therapeutics Price Target to $86 From $85, Maintains Buy Rating

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

Zacks

2 months ago

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move

Motley Fool

2 months ago

Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move

CRISPR Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?

Zacks

2 months ago

CRISPR Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?

CRISPR Therapeutics AG (CRSP): Among Cathie Wood’s Top Stock Picks for 2025

Insider Monkey

2 months ago

CRISPR Therapeutics AG (CRSP): Among Cathie Wood’s Top Stock Picks for 2025

The Zacks Analyst Blog Highlights Amgen, CRISPR, Moderna, Sarepta and Vertex

Zacks

2 months ago

The Zacks Analyst Blog Highlights Amgen, CRISPR, Moderna, Sarepta and Vertex

Why CRISPR Therapeutics AG (CRSP) Outpaced the Stock Market Today

Zacks

2 months ago

Why CRISPR Therapeutics AG (CRSP) Outpaced the Stock Market Today

Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates?

Zacks

3 months ago

Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates?

MT Newswires

3 months ago

HC Wainwright Initiates CRISPR Therapeutics at Buy With $65 Price Target

Jim Cramer Says “CRISPR (CRSP) Keeps Losing Money Like Moderna” – Here’s Why

Insider Monkey

3 months ago

Jim Cramer Says “CRISPR (CRSP) Keeps Losing Money Like Moderna” – Here’s Why

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors

CRISPR Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference

GlobeNewswire

3 months ago

CRISPR Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference

CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know

CRISPR Therapeutics (CRSP) Moves 6.5% Higher: Will This Strength Last?

Zacks

3 months ago

CRISPR Therapeutics (CRSP) Moves 6.5% Higher: Will This Strength Last?

My Top 5 Stocks to Buy in Early 2025

Motley Fool

3 months ago

My Top 5 Stocks to Buy in Early 2025

CRISPR Therapeutics AG (CRSP): The Biotech Stock with Biggest Upside Potential

Insider Monkey

3 months ago

CRISPR Therapeutics AG (CRSP): The Biotech Stock with Biggest Upside Potential

CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell?

Zacks

3 months ago

CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell?

2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows

Motley Fool

3 months ago

2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows

My 10 Top Stocks to Buy to Start the New Year Off Right

Motley Fool

3 months ago

My 10 Top Stocks to Buy to Start the New Year Off Right

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade

Meet the Innovative Growth Stock That Could Rocket 114% to 152% Higher in 2025, According to a Couple of Wall Street Analysts

Motley Fool

3 months ago

Meet the Innovative Growth Stock That Could Rocket 114% to 152% Higher in 2025, According to a Couple of Wall Street Analysts

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2025 Milestones

GlobeNewswire

3 months ago

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2025 Milestones

3 Mid-Cap Stocks That Could Take Off in 2025

Motley Fool

3 months ago

3 Mid-Cap Stocks That Could Take Off in 2025

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

3 months ago

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note

Zacks

3 months ago

CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note

MT Newswires

3 months ago

BofA Securities Adjusts Price Target on CRISPR Therapeutics to $85 From $98, Maintains Buy Rating

CRISPR Therapeutics Proposes New Appointment to the Board of Directors

GlobeNewswire

3 months ago

CRISPR Therapeutics Proposes New Appointment to the Board of Directors

Vertex, startup Orna to partner on gene editing research

BioPharma Dive

3 months ago

Vertex, startup Orna to partner on gene editing research

CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know

Why Is CRISPR Therapeutics AG (CRSP) Among the Top CRISPR Stocks to Invest In?

Insider Monkey

4 months ago

Why Is CRISPR Therapeutics AG (CRSP) Among the Top CRISPR Stocks to Invest In?

CRISPR Therapeutics AG (CRSP): Is This Gene Therapy Stock a Good Buy Right Now?

Insider Monkey

4 months ago

CRISPR Therapeutics AG (CRSP): Is This Gene Therapy Stock a Good Buy Right Now?

CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors

Zacks

4 months ago

CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors

Institutional investors may adopt severe steps after CRISPR Therapeutics AG's (NASDAQ:CRSP) latest 8.3% drop adds to a year losses

Simply Wall St.

4 months ago

Institutional investors may adopt severe steps after CRISPR Therapeutics AG's (NASDAQ:CRSP) latest 8.3% drop adds to a year losses

Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term

Zacks

4 months ago

Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term

This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy?

Motley Fool

4 months ago

This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy?

1 big new Green Flag for CRISPR Therapeutics' Stock

Motley Fool

4 months ago

1 big new Green Flag for CRISPR Therapeutics' Stock

Share on Social Networks: